All CIRS research papers

7,510 papers, newest first · page 67 of 126

  1. How flagellin and Toll-like receptor 5 contribute to enteric infection

    Infection and Immunity · 2007

  2. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

    Nature reviews. Immunology · 2007

  3. Environmental toxins as modulators of antiviral immune responses

    Viral Immunology · 2007

  4. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

    Clinical & Experimental Immunology · 2007

  5. Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-Positive Regulatory T Cells by Th3 Cells Derived from TGF-β T Cell-Transgenic Mice

    The Journal of Immunology · 2007

  6. Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production

    International Immunology · 2007

  7. Concentration of TGF beta-1 in the supernatant of peripheral blood mononuclear cell cultures from patients with early disseminated and chronic Lyme borreliosis

    Advances in medical sciences · 2007

  8. Inhibition of Transforming Growth Factor-β Production in Brain Pericytes Contributes to Cyclosporin A-Induced Dysfunction of the Blood-Brain Barrier

    Cellular and Molecular Neurobiology · 2007

  9. Altered Expression of Basement Membrane-related Molecules in Rat Brain Pericyte, Endothelial, and Astrocyte Cell Lines after Transforming Growth Factor-β1 Treatment

    Drug Metabolism and Pharmacokinetics · 2007

  10. Transforming Growth Factor-β1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase

    Molecular Pharmacology · 2007

  11. Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry

    Journal of Molecular Neuroscience · 2007

  12. Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

    Journal of Molecular Neuroscience · 2007

  13. Role of VIP and PACAP in islet function

    Peptides · 2007

  14. The role of vasoactive intestinal peptide in neuroprotection: interview with Professor Illana Gozes

    Expert opinion on therapeutic targets · 2007

  15. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD

    Peptides · 2007

  16. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice

    Journal of Neurophysiology · 2007

  17. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene

    Yearbook of Pulmonary Disease · 2007

  18. Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential

    Current Pharmaceutical Design · 2007

  19. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair

    Peptides · 2007

  20. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator

    Current Pharmaceutical Design · 2007

  21. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation

    NeuroImmunoModulation · 2007

  22. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders

    Peptides · 2007

  23. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy

    Annals of the Rheumatic Diseases · 2007

  24. Vasoactive intestinal peptide gene alterations in patients with idiopathic pulmonary arterial hypertension

    European Journal of Human Genetics · 2007

  25. HLA-DRB1*1501, -DQB1*0301, - DQB1*0302, -DQB1*0602, and DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis

    International review of neurobiology · 2007

  26. Rigor, transparency, and disclosure needed in mold position paper

    The Journal of Allergy and Clinical Immunology · 2006

  27. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders

    Seminars in Hematology · 2006

  28. Acquired von Willebrand syndrome: features and management

    American Journal of Hematology · 2006

  29. The use of recombinant activated factor VII in congenital and acquired von Willebrand disease

    Blood Coagulation & Fibrinolysis · 2006

  30. Characterization of bitiscetin-2, a second form of bitiscetin from the venom of Bitis arietans: comparison of its binding site with the collagen-binding site on the von Willebrand factor A3-domain

    Journal of Thrombosis and Haemostasis · 2006

  31. Co-cultivation of Streptomyces californicus and Stachybotrys chartarum stimulates the production of cytostatic compound(s) with immunotoxic properties

    Toxicology and Applied Pharmacology · 2006

  32. Streptomyces cheonanensis sp. nov., a novel streptomycete with antifungal activity

    INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2006

  33. Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole

    Cancer Research · 2006

  34. Acute neurotoxic effects of the fungal metabolite ochratoxin-A

    NeuroToxicology · 2006

  35. Can low level exposure to ochratoxin-A cause parkinsonism?

    Journal of the Neurological Sciences · 2006

  36. The role of CD4+ CD25+ regulatory T cells in the pathogenesis of asthma in children

    Zhonghua yi xue za zhi · 2006

  37. The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma

    European Respiratory Journal · 2006

  38. TGF-β: Its Role in Asthma and Therapeutic Potential

    Current Drug Targets · 2006

  39. Activation of protein kinase A improves vascular endothelial dysfunction

    Endothelium · 2006

  40. Mesenchymal stem cells over-expressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation

    Molecular Therapy · 2006

  41. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

    The FASEB Journal · 2006

  42. Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells

    Cellular Signalling · 2006

  43. Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4

    The Journal of Experimental Medicine · 2006

  44. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation

    Journal of Biological Chemistry · 2006

  45. Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS

    Journal of Neurology Neurosurgery & Psychiatry · 2006

  46. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis

    Neurobiology of Disease · 2006

  47. Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging

    Alzheimer Disease & Associated Disorders · 2006

  48. Impact of evidence-based medicine on magnetic resonance spectroscopy

    NMR in Biomedicine · 2006

  49. MRS shows abnormalities before symptoms in familial Alzheimer disease

    Neurology · 2006

  50. The Effect of Drugs for Alzheimer Disease Assessed by Means of Neuroradiological Techniques

    Current Medicinal Chemistry · 2006

  51. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer’s disease: a nonrandomized controlled trial with magnetic resonance spectroscopy

    CNS Drugs · 2006

  52. Cholinesterase inhibitors for Alzheimer’s disease

    Cochrane Database of Systematic Reviews · 2006

  53. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS

    NMR in Biomedicine · 2006

  54. MR spectroscopy of brain white matter in the prediction of dementia

    Neurology · 2006

  55. Proton magnetic resonance spectroscopy in frontotemporal dementia

    Journal of Neurology · 2006

  56. Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years- United States, 2003-2004

    MMWR. Morbidity and mortality weekly report · 2006

  57. Parental Report of Health Conditions and Health Care Use Among Children With and Without Autism

    Archives of Pediatrics and Adolescent Medicine · 2006

  58. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease

    Photo interprétation · 2006

  59. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms

    Journal of Neuroimmunology · 2006

  60. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X permutation

    Journal of Developmental & Behavioral Pediatrics · 2006